Cosmax Nbt (A222040) 주식 개요코스맥스엔비티는 국내 및 해외에서 건강기능식품 회사로 활동하고 있습니다. 자세히 보기A222040 펀더멘털 분석스노우플레이크 점수가치 평가4/6미래 성장0/6과거 실적0/6재무 건전성4/6배당0/6강점공정 가치 추정치보다 낮은 22.1% 에서 거래위험 분석지난 3개월 동안 주가 변동성이 KR 시장과 비교해 높았습니다.모든 위험 점검 보기A222040 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₩Current Price₩7.87k57.7% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-24b330b2016201920222025202620282031Revenue ₩330.3bEarnings ₩32.1bAdvancedSet Fair ValueView all narrativesCosmax Nbt, Inc. 경쟁사PoledSymbol: KOSDAQ:A487580Market cap: ₩127.7bGC WellBeingSymbol: KOSDAQ:A234690Market cap: ₩170.0bCosmax BTISymbol: KOSE:A044820Market cap: ₩173.1bCLIO CosmeticsLtdSymbol: KOSDAQ:A237880Market cap: ₩202.2b가격 이력 및 성과Cosmax Nbt 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가₩7,870.0052주 최고가₩9,200.0052주 최저가₩2,860.00베타0.641개월 변동61.60%3개월 변동127.79%1년 변동55.53%3년 변동38.80%5년 변동-32.45%IPO 이후 변동-45.72%최근 뉴스 및 업데이트New Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.공시 • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea분석 기사 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...분석 기사 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).더 많은 업데이트 보기Recent updatesNew Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.공시 • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea분석 기사 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...분석 기사 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).분석 기사 • May 07There's No Escaping Cosmax Nbt, Inc.'s (KOSDAQ:222040) Muted Revenues Despite A 25% Share Price RiseCosmax Nbt, Inc. ( KOSDAQ:222040 ) shares have continued their recent momentum with a 25% gain in the last month alone...분석 기사 • Apr 24Cosmax Nbt (KOSDAQ:222040) Has No Shortage Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Mar 20Full year 2024 earnings released: ₩279 loss per share (vs ₩314 loss in FY 2023)Full year 2024 results: ₩279 loss per share (improved from ₩314 loss in FY 2023). Revenue: ₩318.0b (down 4.7% from FY 2023). Net loss: ₩5.75b (loss narrowed 11% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.공시 • Mar 08Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, majang-myeon, gyeonggi-do, icheon South Korea분석 기사 • Feb 25Investors Don't See Light At End Of Cosmax Nbt, Inc.'s (KOSDAQ:222040) TunnelCosmax Nbt, Inc.'s ( KOSDAQ:222040 ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing...분석 기사 • Oct 23Lacklustre Performance Is Driving Cosmax Nbt, Inc.'s (KOSDAQ:222040) Low P/SWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$47.7m).Buy Or Sell Opportunity • Aug 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to ₩3,040. The fair value is estimated to be ₩3,812, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has declined by 19%.분석 기사 • Aug 06Cosmax Nbt (KOSDAQ:222040) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Price Target Changed • Jul 03Price target increased by 29% to ₩10,500Up from ₩8,150, the current price target is provided by 1 analyst. New target price is 166% above last closing price of ₩3,940. Stock is down 35% over the past year. The company is forecast to post earnings per share of ₩747 next year compared to a net loss per share of ₩315 last year.분석 기사 • Jun 26Cosmax Nbt, Inc. (KOSDAQ:222040) Looks Inexpensive But Perhaps Not Attractive EnoughWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...분석 기사 • May 21Is Cosmax Nbt, Inc. (KOSDAQ:222040) Trading At A 48% Discount?Key Insights The projected fair value for Cosmax Nbt is ₩7,493 based on 2 Stage Free Cash Flow to Equity Cosmax Nbt is...Reported Earnings • Mar 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: ₩314 loss per share (improved from ₩633 loss in FY 2022). Revenue: ₩333.6b (up 1.7% from FY 2022). Net loss: ₩6.49b (loss narrowed 50% from FY 2022). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 18% per year.분석 기사 • Mar 19Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% PoundingThe Cosmax Nbt, Inc. ( KOSDAQ:222040 ) share price has fared very poorly over the last month, falling by a substantial...분석 기사 • Mar 11Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Jan 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩129.7b (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Mar 26Full year 2022 earnings released: ₩633 loss per share (vs ₩309 loss in FY 2021)Full year 2022 results: ₩633 loss per share (further deteriorated from ₩309 loss in FY 2021). Revenue: ₩328.2b (up 13% from FY 2021). Net loss: ₩13.1b (loss widened 104% from FY 2021). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Nov 30Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be ₩5,427, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 43%.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Price Target Changed • May 13Price target increased to ₩14,000Up from ₩12,000, the current price target is an average from 2 analysts. New target price is 33% above last closing price of ₩10,500. Stock is up 111% over the past year.분석 기사 • Apr 06Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...분석 기사 • Mar 01What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?The big shareholder groups in Cosmax Nbt, Inc. ( KOSDAQ:222040 ) have power over the company. Large companies usually...Is New 90 Day High Low • Feb 26New 90-day low: ₩7,410The company is down 5.0% from its price of ₩7,800 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 13% over the same period.분석 기사 • Feb 02Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five YearsSome stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...분석 기사 • Jan 04Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?Cosmax Nbt, Inc. ( KOSDAQ:222040 ), is not the largest company out there, but it saw a decent share price growth in the...분석 기사 • Dec 09Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Nov 18Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?If you want to know who really controls Cosmax Nbt, Inc. (KOSDAQ:222040), then you'll have to look at the makeup of...Is New 90 Day High Low • Nov 16New 90-day low: ₩7,890The company is down 13% from its price of ₩9,040 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩10,616 per share.Is New 90 Day High Low • Oct 26New 90-day low: ₩7,970The company is down 2.0% from its price of ₩8,170 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,583 per share.주주 수익률A222040KR Personal ProductsKR 시장7D-7.4%-1.2%4.2%1Y55.5%22.5%183.9%전체 주주 수익률 보기수익률 대 산업: A222040은 지난 1년 동안 22.5%의 수익을 기록한 KR Personal Products 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: A222040은 지난 1년 동안 183.9%를 기록한 KR 시장보다 저조한 성과를 냈습니다.주가 변동성Is A222040's price volatile compared to industry and market?A222040 volatilityA222040 Average Weekly Movement13.8%Personal Products Industry Average Movement8.8%Market Average Movement9.5%10% most volatile stocks in KR Market16.7%10% least volatile stocks in KR Market4.9%안정적인 주가: A222040의 주가는 지난 3개월 동안 KR 시장보다 변동성이 컸습니다.시간에 따른 변동성: A222040의 주간 변동성(14%)은 지난 1년 동안 안정적이었지만 KR 종목 중 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트2002513Jin-Hyuck Kwonwww.cosmaxnbt.com.au코스맥스엔비티는 국내 및 해외에서 건강기능식품 회사로 운영되고 있습니다. 또한 독창적인 디자인과 독창적인 브랜드 제조 서비스를 제공합니다. 또한 화장품, 의약품 및 의료용품을 제공합니다.더 보기Cosmax Nbt, Inc. 기초 지표 요약Cosmax Nbt의 순이익과 매출은 시가총액과 어떻게 비교됩니까?A222040 기초 통계시가총액₩161.77b순이익 (TTM)-₩3.65b매출 (TTM)₩308.56b0.5x주가매출비율(P/S)-44.4x주가수익비율(P/E)A222040는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표A222040 손익계산서 (TTM)매출₩308.56b매출원가₩258.96b총이익₩49.60b기타 비용₩53.25b순이익-₩3.65b최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)-177.40총이익률16.07%순이익률-1.18%부채/자본 비율266.6%A222040의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/29 23:48종가2026/05/29 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cosmax Nbt, Inc.는 8명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Young Ok KimDAOL Investment & Securities Co., Ltd.null nullDBS Bank LtdJi KimEugene Investment & Securities Co Ltd.5명의 분석가 더 보기
New Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).
Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
공시 • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea
분석 기사 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...
분석 기사 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).
New Risk • May 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩139.6b market cap, or US$94.6m).
Reported Earnings • Mar 24Full year 2025 earnings released: ₩731 loss per share (vs ₩279 loss in FY 2024)Full year 2025 results: ₩731 loss per share (further deteriorated from ₩279 loss in FY 2024). Revenue: ₩287.5b (down 9.6% from FY 2024). Net loss: ₩15.0b (loss widened 161% from FY 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
공시 • Mar 12Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026Cosmax Nbt, Inc., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, gyeonggi-do, icheon South Korea
분석 기사 • Nov 20Insufficient Growth At Cosmax Nbt, Inc. (KOSDAQ:222040) Hampers Share PriceWhen close to half the companies operating in the Personal Products industry in Korea have price-to-sales ratios (or...
분석 기사 • Jul 28Is Cosmax Nbt (KOSDAQ:222040) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Jul 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩89.6b market cap, or US$64.9m).
분석 기사 • May 07There's No Escaping Cosmax Nbt, Inc.'s (KOSDAQ:222040) Muted Revenues Despite A 25% Share Price RiseCosmax Nbt, Inc. ( KOSDAQ:222040 ) shares have continued their recent momentum with a 25% gain in the last month alone...
분석 기사 • Apr 24Cosmax Nbt (KOSDAQ:222040) Has No Shortage Of DebtSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Mar 20Full year 2024 earnings released: ₩279 loss per share (vs ₩314 loss in FY 2023)Full year 2024 results: ₩279 loss per share (improved from ₩314 loss in FY 2023). Revenue: ₩318.0b (down 4.7% from FY 2023). Net loss: ₩5.75b (loss narrowed 11% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings.
공시 • Mar 08Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025Cosmax Nbt, Inc., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 127-16, deokpyeong-ro 663beon-gil, majang-myeon, gyeonggi-do, icheon South Korea
분석 기사 • Feb 25Investors Don't See Light At End Of Cosmax Nbt, Inc.'s (KOSDAQ:222040) TunnelCosmax Nbt, Inc.'s ( KOSDAQ:222040 ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing...
분석 기사 • Oct 23Lacklustre Performance Is Driving Cosmax Nbt, Inc.'s (KOSDAQ:222040) Low P/SWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$47.7m).
Buy Or Sell Opportunity • Aug 07Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to ₩3,040. The fair value is estimated to be ₩3,812, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.6% over the last 3 years. Earnings per share has declined by 19%.
분석 기사 • Aug 06Cosmax Nbt (KOSDAQ:222040) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Price Target Changed • Jul 03Price target increased by 29% to ₩10,500Up from ₩8,150, the current price target is provided by 1 analyst. New target price is 166% above last closing price of ₩3,940. Stock is down 35% over the past year. The company is forecast to post earnings per share of ₩747 next year compared to a net loss per share of ₩315 last year.
분석 기사 • Jun 26Cosmax Nbt, Inc. (KOSDAQ:222040) Looks Inexpensive But Perhaps Not Attractive EnoughWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
분석 기사 • May 21Is Cosmax Nbt, Inc. (KOSDAQ:222040) Trading At A 48% Discount?Key Insights The projected fair value for Cosmax Nbt is ₩7,493 based on 2 Stage Free Cash Flow to Equity Cosmax Nbt is...
Reported Earnings • Mar 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: ₩314 loss per share (improved from ₩633 loss in FY 2022). Revenue: ₩333.6b (up 1.7% from FY 2022). Net loss: ₩6.49b (loss narrowed 50% from FY 2022). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 18% per year.
분석 기사 • Mar 19Little Excitement Around Cosmax Nbt, Inc.'s (KOSDAQ:222040) Revenues As Shares Take 28% PoundingThe Cosmax Nbt, Inc. ( KOSDAQ:222040 ) share price has fared very poorly over the last month, falling by a substantial...
분석 기사 • Mar 11Here's Why Cosmax Nbt (KOSDAQ:222040) Is Weighed Down By Its Debt LoadLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Jan 31New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩129.7b (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
New Risk • Nov 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩633 loss per share (vs ₩309 loss in FY 2021)Full year 2022 results: ₩633 loss per share (further deteriorated from ₩309 loss in FY 2021). Revenue: ₩328.2b (up 13% from FY 2021). Net loss: ₩13.1b (loss widened 104% from FY 2021). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Nov 30Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be ₩5,427, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 43%.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Director Eun-Il Han was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Price Target Changed • May 13Price target increased to ₩14,000Up from ₩12,000, the current price target is an average from 2 analysts. New target price is 33% above last closing price of ₩10,500. Stock is up 111% over the past year.
분석 기사 • Apr 06Cosmax Nbt (KOSDAQ:222040) Has Debt But No Earnings; Should You Worry?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
분석 기사 • Mar 01What Is The Ownership Structure Like For Cosmax Nbt, Inc. (KOSDAQ:222040)?The big shareholder groups in Cosmax Nbt, Inc. ( KOSDAQ:222040 ) have power over the company. Large companies usually...
Is New 90 Day High Low • Feb 26New 90-day low: ₩7,410The company is down 5.0% from its price of ₩7,800 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 13% over the same period.
분석 기사 • Feb 02Cosmax Nbt (KOSDAQ:222040) Share Prices Have Dropped 76% In The Last Five YearsSome stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...
분석 기사 • Jan 04Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?Cosmax Nbt, Inc. ( KOSDAQ:222040 ), is not the largest company out there, but it saw a decent share price growth in the...
분석 기사 • Dec 09Is Cosmax Nbt (KOSDAQ:222040) Using Debt In A Risky Way?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Nov 18Is Cosmax Nbt, Inc.'s (KOSDAQ:222040) Shareholder Ownership Skewed Towards Insiders?If you want to know who really controls Cosmax Nbt, Inc. (KOSDAQ:222040), then you'll have to look at the makeup of...
Is New 90 Day High Low • Nov 16New 90-day low: ₩7,890The company is down 13% from its price of ₩9,040 on 18 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩10,616 per share.
Is New 90 Day High Low • Oct 26New 90-day low: ₩7,970The company is down 2.0% from its price of ₩8,170 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,583 per share.
